Aytu BioScience AYTU 深 沪
等待开盘 10-23 09:30:00 美东时间
2.28
-0.080
-3.39%
华盛通- 最 高2.35
- 今 开2.32
- 成交量 3.35万股
- 最 低 2.25
- 昨 收 2.36
- 总市值 2259.91万
- 52周最高 2.82
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.95
- 委 比 -5.66%
- 总股本 991.19万
- 历史最高 12920.00
- 量 比 0.35
- 振 幅 4.24%
- 历史最低 0.95
- 每 手 1
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $12.5
Ascendiant Capital analyst Edward Woo maintains Aytu BioPharma (NASDAQ: AYTU) with a Buy and raises the price target from $12 to $12.5.
09-25 20:04
Aytu BioPharma’s Optimistic Earnings Call Highlights ExuA Launch
Aytu BioScience (($AYTU)) has held its Q4 earnings call. Read on for the main h...
09-25 08:02
Aytu BioPharma推出指向价值220亿美元重度抑郁症市场的计划
Aytu BioPharma（AYTU）概述了推出EXXUA的计划，目标是价值220亿美元的重度抑郁症市场。公司正将重心转向处方药，EXXUA提供了一种新的...
09-24 23:23
Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio
Earnings Call Insights: Aytu BioPharma (AYTU) Q4 2025 Management View CEO Joshua Disbrow highlighted "the strong financial performance during the recent fiscal year and perhaps more importantly, the u...
09-24 09:44
Aytu BioPharma Q4 EPS $(2.92) Misses $(0.04) Estimate, Sales $15.135M Miss $17.922M Estimate
Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(2.92) per share which missed the analyst consensus estimate of $(0.04) by 7791.89 percent. This is a 256.1 percent decrease over losses of $(0.82) per share
09-24 04:06
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: Aytu BioPharma (AYTU) AAR Corp. (AIR) MillerKnoll (MLKN) Worthington Enterprises (WOR) Micron Technology (MU) For Seeking Alpha's full earnin...
09-23 22:00
Earnings Scheduled For September 23, 2025
Companies Reporting Before The Bell • AutoZone (NYSE:AZO) is likely to report q...
09-23 16:32
Aytu BioPharma FQ4 2025 Earnings Preview
Aytu BioPharma (NASDAQ:AYTU) is scheduled to announce FQ4 earnings results on Tuesday, September 23rd, after market close. The consensus EPS Estimate is -$0.06 and the consensus Revenue Estimate is $1...
09-23 05:35
